Modern radiation therapy for extranodal nasal-type NK/T-cell lymphoma: risk-adapted therapy, target volume, and dose guidelines from the International Lymphoma …

SN Qi, YX Li, L Specht, M Oguchi, R Tsang, A Ng… - International Journal of …, 2021 - Elsevier
In the multidisciplinary management of early-stage extranodal natural killer/T-cell lymphoma,
nasal type (ENKTCL), with curative intent, radiation therapy is the most efficacious modality …

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review

SJ Kim, SE Yoon, WS Kim - Journal of hematology & oncology, 2018 - Springer
Extranodal natural killer/T cell lymphoma (ENKTL), nasal type, presents predominantly as a
localized disease involving the nasal cavity and adjacent sites, and the treatment of …

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

SN Qi, Y Yang, YQ Song, Y Wang, X He, C Hu… - Blood …, 2020 - ashpublications.org
The present study investigated the survival benefit of non–anthracycline (ANT)-based vs
ANT-based regimens in a large-scale, real-world cohort of patients with extranodal natural …

Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer/T-cell lymphoma

Y Yang, JZ Cao, SM Lan, JX Wu, T Wu, SY Zhu… - JAMA …, 2017 - jamanetwork.com
Importance The long-term survival benefit for radiotherapy (RT) in early-stage extranodal
natural killer/T-cell lymphoma (NKTCL) is not known, and it is unclear whether improved …

Extranodal natural killer/T-cell lymphoma: an overview on pathology and clinical management

E Tse, CP Fox, A Glover, SE Yoon, WS Kim… - Seminars in …, 2022 - Elsevier
Abstract Natural killer (NK)/T-cell lymphomas arise mainly from NK-cells and occasionally T-
cells, and are universally infected with Epstein Barr virus (EBV). They are uncommon …

NCCN guidelines insights: T-cell lymphomas, version 2.2018

SM Horwitz, SM Ansell, WZ Ai, J Barnes… - Journal of the National …, 2018 - jnccn.org
Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's
lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are …

[HTML][HTML] Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas

R Stuver, ZD Epstein-Peterson, SM Horwitz - Haematologica, 2023 - ncbi.nlm.nih.gov
While all peripheral T-cell lymphomas are uncommon, certain subtypes are truly rare, with
less than a few hundred cases per year in the USA. There are often no dedicated clinical …

Current treatment approaches for NK/T-cell lymphoma

M Yamaguchi, K Miyazaki - Journal of clinical and experimental …, 2017 - jstage.jst.go.jp
Extranodal NK/T-cell lymphoma, nasal type (ENKL), is a form of lymphoma characterized by
preferential extranodal involvement, Epstein-Barr virus (EBV) association, and geographic …

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: a multicenter …

XW Deng, JX Wu, T Wu, SY Zhu, M Shi, H Su… - Radiotherapy and …, 2018 - Elsevier
Purpose This study aimed to clarify the benefit of radiotherapy (RT) in patients with early-
stage extranodal NK/T-cell lymphoma (NKTCL) who achieve a complete response (CR) after …

T-cell lymphomas, a challenging disease: types, treatments, and future

H Ma, M Abdul-Hay - International journal of clinical oncology, 2017 - Springer
T-cell lymphomas are rare and aggressive malignancies associated with poor outcome,
often because of the development of resistance in the lymphoma against chemotherapy as …